Covance Data and Technology

サービス

データ & テクノロジー

Covance utilizes unrivaled, proprietary data and technology to improve clinical study outcomes.

Xcellerate テクノロジースイート

Xcellerate® is a suite of data and technology enabling solutions designed to increase drug and medical device development efficiency, reduce timelines, improve compliance, and drive commercialization.

より良い研究デザイン 研究におけるリクルートを改善 研究リスクの低減 業務に対する洞察 データ品質の確保 Access Central Lab Information データを強化 製品アクセスを最大限に拡大 患者様の安全を変革

By the Numbers

Site Activation to Last Patient in

4.2

Months Faster vs. The Industry
Oncology - Global - Phase I-IV

Recruitment Rate

14%

Faster vs. The Industry
Oncology - Global - Phase I-IV

Screen Failure

26%

Fewer vs. The Industry
Oncology - Global - Phase I-IV

Patient Density

63%

Better vs. The Industry
Cardiology - Global - Phase I-IV

Photo of computer monitor with charts and graphs

Featured Webinar

Measuring Success of a Quality Risk Management Approach

As regulatory guidance and data collection in clinical trials has evolved, sponsors face pressure to balance quality, productivity and cost for risk management and monitoring. The industry has adopted risk-based quality management (RBQM), yet the methodology is inconsistent. There is no standard way to measure the impact of the different approaches to RBQM on the effectiveness of clinical trial management. Learn more about our approach to establishing and tracking metrics - including those that could apply across the industry - to measure the success of an RBQM approach.

Watch webinar

Testimonial

「市場の誰も患者様の治験に参加する、しない理由に関してここまで深い洞察を持っていないでしょう。 This is a differentiator and extremely innovative" VP, Top 5 Pharma

デモをリクエスト

Increase the efficiency and effectiveness of your clinical trials with Xcellerate

詳細